08:30
Arrival, exhibition and networking
09:00
Welcome and introductions
Dr Kevin Fernando, GP Partner North Berwick Health Centre, GP with Specialist Interest in CVRM
Dr Patrick Holmes, GP Partner, St. George’s Medical Practice
09:15
SESSION 1 – CVRM medicine: Taking a holistic approach
Chaired by Dr Patrick Holmes
Dr Kevin Fernando, GP Partner North Berwick Health Centre, GP with Specialist Interest in CVRM
09:30
SESSION 2 - CVRM medicine: Taking a new approach to existing cardiovascular challenges
Chaired by Dr Patrick Holmes
Dr Joe Martins, Consultant Interventional Cardiologist, RCP and BCS West Midlands Cardiology Speciality Advisor, Cardiology Clinical Service Lead, The Dudley Group NHS Foundation Trust
09:50
SESSION 3 – Type 2 diabetes: exploring the metabolic consequences
Chaired by Dr Patrick Holmes
Prof David Strain, Associate Professor of Cardiometabolic Health at the University of Exeter Medical School
10:10
SESSION 4 - Metabolic dysfunction-associated steatotic liver disease (MASLD) – a threat to public health?
Chaired by Dr Patrick Holmes
Dr Kevin Fernando, GP Partner North Berwick Health Centre, GP with Specialist Interest in CVRM
10:30
Panel Q&A
Chaired by Dr Patrick Holmes
Dr Kevin Fernando, Dr Joe Martins, Dr David Strain
10:45
Refreshments, exhibition and networking
11:00
Improving access to cardiorenal protection in T2DM: implementing NICE guidance
This is a promotional symposium sponsored and organised by AstraZeneca, intended for GB HCPs only.
Dr Janaka Karalliedde FRCP PhD, Clinical Reader in Diabetes & Cardiovascular Disease, King’s College, London
11:40
SESSION 6 - BREAKOUT STREAMS
1. Practical advice on achieving QoF targets for lipid management in CVD and Diabetes
Bev Bostock, Advanced Nurse Practitioner and PhD Student
Prof Ahmet Fuat, GPSI in Cardiology Darlington and Honorary Professor of Primary Care Cardiology at Durham University
2. Meeting the challenge of polypharmacy in CVRM disease
Nadia Malik, Practice Pharmacist, Queens Park Medical Centre with an interest in diabetes.
Vicky Ruszala, Specialist Pharmacist in cardiology and heart failure, North Bristol NHS Trust
3. CKD: Understanding the evidence, a workshop focusing on what to do next and when
Prof Raj Thakkar, PCCS President and CKD representative, GP, Primary care cardiology lead, Oxford AHSN, Honorary Visiting Professor, Cardiff University.
Dr William Hinchliffe, Renal and General Physician, South Tyneside and Sunderland
12:15
Lunch and networking
13:00
A stepwise approach to lipid management – What more can we do in primary care
This promotional symposium has been sponsored by Daiichi Sankyo UK for which Daiichi Sankyo UK is fully responsible. Daiichi Sankyo medicines will be discussed during this sponsored symposium
Niraj Lakhani, Lead Clinical Pharmacist, Willows Health, Pharmacist Adviser to the Royal College of General Practitioners (RCGP) for Primary Care Development
13:40
SESSION 8 - Leadership and change management: Lessons from type 1 diabetes
Prof Partha Kar, National Specialty Advisor for Diabetes, NHSE, Consultant in Diabetes & Endocrinology, Portsmouth Hospitals NHS Trust
14:00
SESSION 9 - BREAKOUT STREAMS
1. Identifying priorities for change in CVRM medicine
Prof Partha Kar, National Specialty Advisor for Diabetes, NHSE, Consultant in Diabetes & Endocrinology, Portsmouth Hospitals NHS Trust
2. Lifestyle and obesity in CVRM disease
Dr Varun Anand, GP with a special interest in Lifestyle Medicine
3. Current treatment updates and future therapies in Diabetes
Phil Newland-Jones, Consultant Pharmacist in Diabetes and Endocrinology, University Hospitals Southampton NHS Foundation Trust.
Dr Eimear Darcy, GP Partner with an interest in Type Two Diabetes, Cardiovascular Renal Metabolic Review. Grange Family Practice Omagh Northern Ireland
14:45
Refreshments, exhibition and networking
15:00
Current Insights into SGLT2 inhibitors
Dr Thomas Barber, Associate Professor and Honorary Consultant Endocrinologist, University of Warwick & University Hospitals Coventry and Warwickshire
This session has been organised and sponsored by A. Menarini Farmaceutica Internazionale SRL
15:40
SESSION 11 – CVRM medicine: Interdisciplinary view
Chaired by Dr William Hinchliffe
Dr Brendon Neuen, Senior Research Fellow, Renal and Metabolic Program, Nephrologist and Director, Kidney Trials Unit, Royal North Shore Hospital
Dr Muthu Vaduganathan, Cardiologist and Clinical Trialist at Brigham and Women's Hospital and Harvard Medical School
16:25
SESSION 12 - Expert Panel: Plenary | CVRM challenges: Question time
Chaired by Dr Kevin Fernando & Dr Patrick Holmes
Expert panel:
Will Hinchliffe, Partha Kar, Brendon Neuen, Muthu Vaduganathan, Bev Bostock, Nadia Malik
16:45
Closing remarks
Dr Kevin Fernando and Dr Patrick Holmes